The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma-Reference-Cited by-同舟云学术

The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma

Published:2020 Issue:10 Volume:67 Page:989-995
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Oki Kenji¹,Gomez-Sanchez Celso E.²

Affiliation:

1. Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

2. Division of Endocrinology, G.V. (Sonny) Montgomery VA Medical Center and Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS, USA

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/67/10/67_EJ20-0478/_pdf

Reference47 articles.

1. 1 Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, et al. (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101: 1889–1916.

2. 2 Choi M, Scholl UI, Yue P, Björklund P, Zhao B, et al. (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331: 768–772.

3. 3 Azizan EA, Poulsen H, Tuluc P, Zhou J, Clausen MV, et al. (2013) Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet 45: 1055–1060.

4. 4 Beuschlein F, Boulkroun S, Osswald A, Wieland T, Nielsen HN, et al. (2013) Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet 45: 440–444, 444e1–2.

5. 5 Akerstrom T, Maharjan R, Sven Willenberg H, Cupisti K, Ip J, et al. (2016) Activating mutations in CTNNB1 in aldosterone producing adenomas. Sci Rep 6: 19546.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saline suppression testing-induced hypocalcemia and implications for clinical interpretations;European Journal of Endocrinology;2024-07-29

2. Adrenocortical Tumor Associated With Pathogenic Variant in KCNJ5 and DNA Methylation of CYP11B2 in Primary Aldosteronism;JCEM Case Reports;2024-06-27

3. Developing the novel diagnostic model and potential drugs by integrating bioinformatics and machine learning for aldosterone-producing adenomas;Frontiers in Molecular Biosciences;2024-01-04

4. Sfrp2 regulates the WNT/β-catenin pathway to slow the development of aldosterone-producing adenoma;Cardiovascular Diagnosis and Therapy;2023-06

5. Primary aldosteronism (Conn's syndrome);Endocrine Hypertension;2023